Sensyne Health plc Appointment of Chief Scientific Officer
22 juil. 2021 07h00 HE
|
Sensyne Health
Appointment of Chief Scientific OfficerDr. David Ruau joins Sensyne Health from Bayer Pharmaceuticals Oxford, U.K. 22 July 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company”), the...
Sensyne Health Interim Results
21 janv. 2021 07h00 HE
|
Sensyne Health
Sensyne Health Interim Results Oxford, UK; 21 January 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces its Interim Results...
Sensyne Health appoints President, North America, to lead US expansion
13 nov. 2020 07h00 HE
|
Sensyne Health
Sensyne Health appoints President, North America, to lead US expansion Oxford, U.K. 13 November 2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical...
Sensyne Health Full Year Results
30 sept. 2020 07h00 HE
|
Sensyne Health
Sensyne Health Full Year Results Oxford, U.K. 30 September 2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces its audited...
Sensyne Health announces the UK launch of ‘SENSETM’ - a clinical algorithm engine, created in partnership with Microsoft
03 sept. 2020 07h00 HE
|
Sensyne Health
Sensyne Health announces the UK launch of ‘SENSETM’ - a clinical algorithm engine, created in partnership with Microsoft ‘SENSETM’ provides a real-time decision support service for clinicians across...
Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence
31 juil. 2019 07h00 HE
|
Sensyne Health
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and clinical AI for the patient-centred management and treatment of chronic disease
28 janv. 2019 07h01 HE
|
Sensyne Health
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and...
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States
28 janv. 2019 07h01 HE
|
Sensyne Health
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States Entry to US market grows Sensyne Health database on...
Sensyne Health and Wye Valley NHS Trust sign Strategic Research Agreement
28 janv. 2019 07h01 HE
|
Sensyne Health
Sensyne Health and Wye Valley NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 1.36 million hospital admissions, for analysis using...
Sensyne Health and George Eliot Hospital NHS Trust sign Strategic Research Agreement
28 janv. 2019 07h01 HE
|
Sensyne Health
Sensyne Health and George Eliot Hospital NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 746,000 hospital admissions, for analysis...